Drug Profile
Research programme: monoclonal antibody therapeutics - Chlorogen
Latest Information Update: 30 Jul 2007
Price :
$50
*
At a glance
- Originator Chlorogen
- Class Monoclonal antibodies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pancreatic cancer
Most Recent Events
- 05 Oct 2005 Preclinical trials in Pancreatic cancer in USA (Injection)